Invention Application
US20150329541A1 APOPTOSIS INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES
审中-公开
用于治疗癌症和免疫和自发性疾病的疫苗诱导剂
- Patent Title: APOPTOSIS INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES
- Patent Title (中): 用于治疗癌症和免疫和自发性疾病的疫苗诱导剂
-
Application No.: US14694965Application Date: 2015-04-23
-
Publication No.: US20150329541A1Publication Date: 2015-11-19
- Inventor: Milan Bruncko , Hong Ding , George A. Doherty , Steven W. Elmore , Lisa A. Hasvold , Laura Hexamer , Aaron R. Kunzer , Xiaohong Song , Andrew J. Souers , Gerard M. Sullivan , Zhi-Fu Tao , Gary T. Wang , Le Wang , Xilu Wang , Michael D. Wendt , Robert Mantei , Todd M. Hansen
- Applicant: AbbVie Inc. , Genentech, Inc. , The Walter and Eliza Hall Institute of Medical Research
- Main IPC: C07D471/04
- IPC: C07D471/04
Abstract:
Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.
Information query
